Hyperhomocyst(e)inemia is associated with impaired endothelium- dependent vasodilation in humans

Circulation

Volumn 95, Issue 5, 1997, Pages 1119-1121

  Tawakol, Ahmed ^a   Omland, Torbjørn ^a   Gerhard, Marie ^a   Wu, James T ^b   Creager, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

endothelium; endothelium derived factors; homocysteine; vasodilation

Indexed keywords

GLYCERYL TRINITRATE; HOMOCYSTEINE; NITRIC OXIDE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPEREMIA; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; RISK FACTOR; VASODILATATION;

EID: 0031018333     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.5.1119     Document Type: Article

References (20)

1. Selhub J, Jacques PF, Wilson PF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
2. Ubbink JB, Vermaac WJH, van der Merwe A, Becker PJ. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1992;55:1154-1160.
3. Kang S-S, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88:1463-1469.
4. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullman D, Tishler PV, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
5. Malinow MR. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 1990;81:2004-2006.
6. Selhub J, Jacques PF, Boston AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
7. Stamler JS, Osborn JA, Jaraji O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
8. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest. 1996;98:24-29.
9. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR, Hopkins PN. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994;40:552-561.
10. Sorenson KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Noninvasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. Br Heart J. 1995;74:247-253.
11. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, Creager MA. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol. 1996;78:1210-1214.
12. Celermajer DS, Sorenson KE, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocysteinuria but not in their heterozygous parents. J Am Coll Cardiol. 1993;22:854-858.
13. Upchurch GR, Welch GN, Randev N, Fabian A, Keaney J Jr, Loscalzo J. The effect of homocysteine on endothelial nitric oxide production. FASEB J. 1995;9:A876. Abstract.
14. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996;98:5-7.
15. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986;77:1370-1376.
16. Blom HJ. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinemia. Eur J Clin Invest. 1995;25:149-154.
17. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995;270:319-324.
18. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992;89:10-18.
19. Franken DG, Boers GH, Blom HJ, Trijbels FJ, Kloppenborg PW. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb. 1994;14:465-470.
20. Naurath HJ, Joosten E, Rizler R, Stabler SP, Lindenbaum J. Effects of vitamin B12, folate, and vitamin B6 supplementation in elderly people with normal serum vitamin concentrations. Lancet. 1995;346:85-89.